$5.73
2.8498.21%
Last update: Nov 11, 6:43 PM
Addex Therapeutics Ltd
ADXNNASDAQ
Addex Therapeutics fell 67.1% from $8.78 to $2.89, behind the S&P 500's +9.8%. Its worst day was Aug 20 (−20.4%), and its low came Nov 9 at $2.74.
Nov 11, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Addex Therapeutics closed at its highest level of the year, 2.1% above where the year started.
+2.1% · S&P 500 −1.7%
EPS of $-1.50 was reported on $62,500.00 revenue.
+3.5% · S&P 500 +0.1%
Story events cover the past 12 months · Times ET
Addex Therapeutics shares rose 12.2%, while the S&P 500 rose 2.5%.
+12.2%, the year's best day · S&P 500 +2.5%
EPS of $-1.50 was reported on $20,020.00 revenue.
+4.3% · S&P 500 +1.0%
EPS of $-1.53 was reported on $10,214.00 revenue.
−4.8% · S&P 500 +0.1%
Addex Therapeutics shares fell 20.4%, while the S&P 500 fell 0.8%.
−20.4%, the year's worst day · S&P 500 −0.8%
EPS of $-2.16 was reported on $12,650.00 revenue.
−19.2% · S&P 500 −0.7%
Where it ended: a close of $2.89 on Nov 10, 2026. Up next: Q3 2026 earnings on Nov 23, 2026.
Nothing in the past 12 months.
All ADXN analyst actionsNothing in the past 12 months.
All ADXN dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for ADXN and SPY from Benzinga historical bars. Not investment advice.
